Abstract
Study objectives
The aims of the study were to examine the frequency of side effects and fatigue in ambulatory cancer patients and to analyse how these symptoms are reflected in patient satisfaction.
Setting
Private practices (N = 41) and day hospitals (N = 8) in Germany took part in the study.
Participants
The respondents were 4,538 patients with cancer (response rate: 82%). The diagnoses were: 25% breast cancer, 21% colorectal cancer, 11% lymphomas and 12% haematological malignancies; mean age 63.5 years; 57% female.
Measurements
The 2004 PASQOC® questionnaire contained 63 problem-oriented items which covered patient satisfaction for 15 dimensions of care. One item specifically assessed the prevalence of 17 different side effects. A score reflecting the severity of fatigue (fatigue index) was computed from three additional questions. For statistical analysis of patient satisfaction, the problem frequency was computed for each item.
Results
The most frequent single side effects were fatigue (60%), hair loss (54%), nausea (51%), sleep disturbance (42%), weight loss (36%), diarrhoea (32%) and mouth ulcerations (31%). The mean number of side effects was 5 per patient (range 0 to 17). The fatigue index revealed that 42% of subjects complained of moderate and 28% of severe fatigue. Both the total number of side effects and the fatigue score were negatively associated with patient satisfaction.
Conclusions
Side effects and especially fatigue are frequent problems in cancer patients and are related to the patients’ assessment of cancer care. Routine symptom assessment may identify patients who require more comprehensive supportive care.
Similar content being viewed by others
References
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
Carr D, Goudas L, Lawrence D (2002) Management of cancer symptoms: pain, depression, and fatigue. Evidence Report/Technology Assessment No. 61 (Prepared by the New England Medical Center Evidence-based Practice Center under Contract No 290-97-0019) AHRQ Publication No. 02-E032
Chang VT, Hwang SS, Feuerman M, Kasimis BS (2000) Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer 88:1175–1183
Cleary PD (2006) The increasing importance of patient surveys. Quality and Safety in Health Care 8:212
Coulter A (2006) Can patients assess the quality of health care. BMJ 333:1–2
Dodd MJ, Miaskowski C, Lee KA (2004) Occurrence of symptom clusters. J Natl Cancer Inst Monogr 32:76–78
Epstein JB, Emerton S, Kolbinson DA, Le ND, Phillips N, Stevenson-Moore P, Osoba D (1999) Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21:1–11
Hoekstra J, de VR, van Duijn NP, Schade E, Bindels PJ (2006) Using the symptom monitor in a randomized controlled trial: the effect on symptom prevalence and severity. J Pain Symptom Manage 31:22–30
Homsi J, Walsh D, Rivera N, Rybicki LA, Nelson KA, Legrand SB, Davis M, Naughton M, Gvozdjan D, Pham H (2006) Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer 14:444–453
Kleeberg UR, Feyer P, Guenther W, Behrens M (2008) Patient satisfaction in outpatient cancer care: a prospective survey using the PASQOC questionnaire. Support Care Cancer; online first DOI 10.1007/s00520-007-0362-4
Kleeberg UR, Tews JT, Ruprecht T, Hoing M, Kuhlmann A, Runge C (2005) Patient satisfaction and quality of life in cancer outpatients: results of the PASQOC study. Support Care Cancer 13:303–310
Miaskowski C, Dodd M, Lee K (2004) Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr 32:17–21
Moro C, Brunelli C, Miccinesi G, Fallai M, Morino P, Piazza M, Labianca R, Ripamonti C (2006) Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer 14:30–37
National Research Corporation (2003) Development and Validation of the Picker Ambulatory Oncology Survey Instrument in Canada
Paice JA (2004) Assessment of symptom clusters in people with cancer. J Natl Cancer Inst Monogr 32:98–102
Patrick DL, Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B, Link MP, Lustig C, McLaughlin J, Reid LD, Turrisi AT III, Unutzer J, Vernon SW (2004) National Institutes of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15–17, 2002. J Natl Cancer Inst Monogr 32:9–16
Potter J, Hami F, Bryan T, Quigley C (2003) Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med 17:310–314
Rüffer JU (2006) Fatigue—das unterschätze symptom. Im Focus Onkologie 10:3333–3336
Smets EM, Garssen B, Bonke B, de Haes JC (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325
Stone P, Richards M, A’Hern R, Hardy J (2000) A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 11:561–567
Vainio A, Auvinen A (1996) Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. J Pain Symptom Manage 12:3–10
Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8:175–179
Acknowledgements
The authors are indebted to the participating study sites, the dedicated staff, Prof. Mühlig for validation of the questionnaire and in particular the participating patients and their relatives.
We thank Prof. Dr. Gratiana Steinkamp, Hannover, who provided medical writing services on behalf of GlaxoSmithKline GmbH & Co. KG, Munich, Germany. This study has been sponsored by GlaxoSmithKline. PASQOC® is a trade mark of GlaxoSmithKline.
Author information
Authors and Affiliations
Corresponding author
Additional information
Presented as an invited lecture at the MASCC/ISOO 20th Anniversary International Symposium Supportive Care in Cancer in St. Gallen, June 2007.
Rights and permissions
About this article
Cite this article
Feyer, P., Kleeberg, U.R., Steingräber, M. et al. Frequency of side effects in outpatient cancer care and their influence on patient satisfaction—a prospective survey using the PASQOC® questionnaire. Support Care Cancer 16, 567–575 (2008). https://doi.org/10.1007/s00520-008-0422-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-008-0422-4